Breast Imaging Market Analysis

Breast Imaging Market Analysis

To get key market trends

  Download Free Sample

The breast imaging market by technology is segmented into ionizing and non-ionizing breast imaging. The ionizing segment is further segmented into mammography, cone-beam computed tomography (CBCT), positron emission tomography & computed tomography (PET-CT), positron emission mammography (PEM) and molecular breast imaging (MBI). The non-ionizing segment is categorized into MRI, thermography, ultrasound, optical imaging, automated whole-breast ultrasound and electric impedance tomography. Further, mammography segment is subdivided into analog mammography, full-field digital mammography and digital breast tomosynthesis.

The ionizing breast imaging segment is expected to witness CAGR of 8.4% by 2032. Rising prevalence of breast cancer globally coupled with increasing awareness about the importance of early detection are driving the demand for ionizing breast imaging technologies. Governments and healthcare organizations are implementing breast cancer screening programs and promoting awareness campaigns. Also, growing need for mammography modalities owing to integration of advanced technologies such as 3D mammography and digital breast tomosynthesis for precised cancer detection.

The breast imaging market by end user is categorized into hospitals, diagnostic imaging centers, ambulatory surgical centers and others. Hospitals segment held largest revenue size accounting for over USD 2 billion in 2022.The high segment growth is owing increasing prevalence of breast cancer worldwide.
 

Hospitals are incorporating breast imaging technology into their cancer screening and diagnostic services, utilizing the latest trends to provide more accurate, efficient, and accessible breast cancer screening and diagnostic services to their patients bolstering segmental evolution potential. Increasing usage of advanced imaging technologies in hospital settings for screening breast tissues providing effective outcomes along with presence of skilled professionals will contribute towards its higher revenue share.

U.S. breast imaging market accounted for over USD 2 billion in 2022. Rising prevalence rate of breast cancer across the nation is driving the product requirement. For instance, in 2022, according to American Cancer Society, approximately 339,250 new cases of breast cancer and second most cause of mortality related to cancer among women in the U.S. Rising focus towards early detection and screening leading to a higher demand for breast imaging technologies in the U.S.

Furthermore, adoption of sophisticated imaging modalities such as contrast-enhanced mammography and digital breast tomosynthesis (DBT) among clinical facilities for improved accuracy and detection rates of breast abnormalities will accelerate market revenue size. Further, high healthcare spending on cancer diagnostics and management, favorable reimbursement scenario will boost the U.S. market in near future.